ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,594,000 | -47.6% | 61,766 | +8.5% | 0.01% | -57.1% |
| Q4 2020 | $3,044,000 | +57.1% | 56,947 | +21.2% | 0.01% | +27.3% |
| Q3 2020 | $1,938,000 | -4.2% | 46,985 | +12.6% | 0.01% | -8.3% |
| Q2 2020 | $2,022,000 | +137.0% | 41,713 | +9.9% | 0.01% | +200.0% |
| Q1 2018 | $853,000 | -26.7% | 37,947 | -1.7% | 0.00% | -33.3% |
| Q4 2017 | $1,163,000 | -18.7% | 38,615 | +1.8% | 0.01% | -14.3% |
| Q3 2017 | $1,430,000 | -34.7% | 37,950 | -51.6% | 0.01% | +16.7% |
| Q2 2017 | $2,190,000 | +62.6% | 78,490 | +100.3% | 0.01% | -25.0% |
| Q1 2017 | $1,347,000 | -12.2% | 39,192 | 0.0% | 0.01% | -11.1% |
| Q4 2016 | $1,534,000 | -32.1% | 39,192 | -44.8% | 0.01% | -35.7% |
| Q3 2016 | $2,259,000 | +5.5% | 71,001 | +7.6% | 0.01% | 0.0% |
| Q2 2016 | $2,142,000 | – | 65,989 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |